Data / Form D filings / Altesa BioSciences, Inc.
Altesa BioSciences, Inc.: Form D filings
Altesa BioSciences, Inc., a pharmaceuticals company in College Park, GA, filed 3 Form D notices with the SEC between 2023 and 2026. The latest, on February 23, 2026, reports $75 million sold of a $75 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1930 HARVARD AVENUE, College Park, GA, 30337
- Phone
- (703) 795-4274
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1960618
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | New notice | $74,999,986 | $74,999,986 | 17 | Feb 13, 2026 | sec.gov | |
| Jul 7, 2023 | Amendment | $35,000,000 | $35,000,000 | 18 | Dec 22, 2022 | sec.gov | |
| Jan 5, 2023 | New notice | $30,000,000 | $14,864,973 | $15,135,027 | 16 | Dec 22, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Clerici | Executive Officer | |
| Brett Giroir | Executive Officer, Director | |
| Seth Rudnick | Director | |
| Ittai Harel | Director | |
| Moncef Slaoui | Director | |
| Nicholas Williams | Director | |
| Andrew Drechsler | Executive Officer | |
| Jon Edwards | Director |
Other pharmaceuticals companies in Georgia that filed recently
- Laurentide Therapeutics Inc. $99,999 · Sep 28, 2026
- LifeCyte Innovations, Inc. $1 million · Aug 20, 2026
Every Form D from the week of Feb 23, 2026 · All recent filings in Georgia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Altesa BioSciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.